Cargando…
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), a...
Autores principales: | Lee, Eudocia Q, Selig, Wendy, Meehan, Clair, Bacha, Jeffrey, Barone, Amy, Bloomquist, Erik, Chang, Susan M, de Groot, John F, Galanis, Evanthia, Hassan, Islam, Kalidas, Chitkala, Khasraw, Mustafa, Kvedar, Joseph C, Lassman, Andrew B, Puduvalli, Vinay, Sahebjam, Solmaz, Schwamm, Lee H, Tamir, Sharon, Welch, Mary, Yung, W K Alfred, Zadeh, Gelareh, Arons, David, Wen, Patrick Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083574/ https://www.ncbi.nlm.nih.gov/pubmed/33822177 http://dx.doi.org/10.1093/neuonc/noab082 |
Ejemplares similares
-
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
por: Tan, Aaron C, et al.
Publicado: (2021) -
Ethics roundtable debate: Child with severe brain damage and an underlying brain tumour
por: Gunn, Scott, et al.
Publicado: (2004) -
PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities
por: Sim, Hao-Wen, et al.
Publicado: (2022) -
The microenvironment of brain metastases from solid tumors
por: Srinivasan, Ethan S, et al.
Publicado: (2021) -
Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases
por: Tan, Aaron C., et al.
Publicado: (2022)